Shenzhen Rongda Photosensitive & Technology Co., Ltd. Class A

Shenzhen Rongda Photosensitive & Technology Co., Ltd. Class A

SSZSE:300576
24.12
CNY
+1.52
(+6.73%)
0.23EPS
110.14P/E
10.80BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.9
1.03
1.04
1.04
1.02
1.18
1.26
1.5
2.14
2.03
2.55
2.4
2.63
2.94
Basic EPS, GAAP
0.09
0.09
0.12
0.11
0.1
0.12
0.1
0.16
0.11
0.15
0.27
0.31
0.29
0.24
Free Cash Flow per Basic Share
0.02
0.01
0.09
0.05
-0.05
-0.13
-0.02
0.02
0.1
0.17
-0.59
-0.42
-0.04
- -
Dividend per Share
0.01
0.02
0.04
0.05
0.02
0.03
0.03
0.02
0.03
0.03
0.03
0.05
0.07
- -
Book Value per Share
0.65
0.73
0.81
1.05
1.14
1.22
1.29
1.43
1.67
2.06
3.19
3.49
4.25
4.4
Tangible Book Value per Share
0.58
0.66
0.75
1.01
1.09
1.17
1.25
1
1.23
1.59
2.74
3.04
3.79
3.92
Basic Weighted Avg Shares
271
267
267
300
355
360
363
363
367
363
313
396
406
403
Sales/Revenue/Turnover
243
275
277
314
363
423
455
544
786
735
799
949
1,069
1,186
Operating Margin (%)
14.23
13.11
13.36
13.37
11.41
10.99
10.49
11.83
6.61
8.56
15.54
16.41
14.26
11.79
Depreciation Expense
3
3
4
4
4
4
8
13
18
20
21
22
36
- -
Net Income, GAAP
24
24
33
34
37
42
38
57
40
53
85
122
118
98
Effective Tax Rate (%)
19.11
17.17
18.14
15.64
12.76
14.22
17.57
9.66
12.37
10.25
13.11
13.34
17.4
19.84
Profit Margin (%)
9.68
8.88
12.02
10.9
10.14
9.96
8.31
10.45
5.09
7.17
10.69
12.89
11.05
8.26
Working Capital
122
137
156
298
298
269
258
288
377
439
744
663
903
895
LT Debt
- -
- -
- -
- -
- -
- -
- -
6
116
5
10
7
4
2
Total Equity
175
195
219
378
408
438
463
512
609
775
1,251
1,368
1,721
1,786
Return on Invested Capital (%)
11.65
12.24
14.05
10.6
9.28
9.47
8.58
11.9
6.55
6.89
8.39
9.41
7.84
- -
Return on Capital (%)
13.48
12.75
15.67
11.11
9.21
10
8.4
11.56
7.08
7.21
8.5
9.26
7.63
- -
Return on Common Equity (%)
14.33
13.2
16.09
11.44
9.38
9.97
8.4
11.65
7.19
7.7
8.5
9.39
7.69
- -

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
3
3
3
LT Borrowings
- -
- -
- -
LT Finance Leases
4
3
2
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
403
404
404
Market Capitalization
12,306
20,677
10,803

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
1,254
1,273
1,396
Cash, Cash Equivalents & STI
364
419
448
Accounts Receivable, Net
490
506
546
Inventories
164
185
183
Total Current Liabilities
361
391
501
Payables & Accruals
- -
- -
- -
ST Debt
3
3
3
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
24.73%
28.57%
25.81%
Free Cash Flow
-27.49%
15.37%
-90.63%
Net Income, GAAP
16.88%
20.81%
-3.45%
Sales/Revenue/Turnover
15.07%
15.62%
12.58%
Total Cash Common Dividend
18.07%
32.07%
48.41%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
205
239
243
262
949
2025
242
264
- -
286
1,069
2026
271
301
328
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.09
0.09
0.08
0.04
0.31
2025
0.09
0.09
- -
0.05
0.29
2026
0.07
0.04
0.09
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.05
2025
- -
- -
- -
- -
0.07
2026
- -
- -
- -
- -
- -

Company Description

CEO
Yong Huang
Full Time Employees
794
Sector
Process industries
Industry
Chemicals: specialty
Address
R&D Building of Lixin Lake Shenzhen GD China 518103
IPO Date
Dec 20, 2016
Website
szrd.com
Business
Shenzhen RongDa Photosensitive Science & Technology Co., Ltd. develops, produces, and sells electronic photosensitive chemical materials within China and internationally. Established in 1996 and based in Shenzhen, China, the company specializes in a comprehensive range of photosensitive chemicals. Its offerings include various photoresists and inks for printed circuit boards (PCBs), display manufacturing, and semiconductor production. These products serve critical roles across the electronic information industry, contributing to the fabrication of displays, integrated circuits, and advanced PCBs.